BlackRock’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12B | Buy |
|
|||||
|
2025
Q1 | $12B | Buy |
|
|||||
|
2024
Q4 | $12B | Buy |
|
|||||
|
2024
Q3 | $12.6B | Buy |
|
|||||
|
2024
Q2 | $11.9B | Sell |
|
|||||
|
2024
Q1 | $12B | Sell |
|
|||||
|
2023
Q4 | $12.5B | Sell |
|
|||||
|
2023
Q3 | $14.6B | Sell |
|
|||||
|
2023
Q2 | $16.3B | Sell |
|
|||||
|
2023
Q1 | $18.2B | Buy |
|
|||||
|
2022
Q4 | $22.7B | Buy |
|
|||||
|
2022
Q3 | $18.9B | Sell |
|
|||||
|
2022
Q2 | $22.8B | Buy |
|
|||||
|
2022
Q1 | $21.1B | Sell |
|
|||||
|
2021
Q4 | $24.2B | Sell |
|
|||||
|
2021
Q3 | $17.7B | Buy |
|
|||||
|
2021
Q2 | $15.9B | Buy |
|
|||||
|
2021
Q1 | $14.7B | Buy |
|
|||||
|
2020
Q4 | $14.6B | Sell |
|
|||||
|
2020
Q3 | $15.2B | Sell |
|
|||||
|
2020
Q2 | $14B | Buy |
|
|||||
|
2020
Q1 | $13.8B | Sell |
|
|||||
|
2019
Q4 | $16.7B | Sell |
|
|||||
|
2019
Q3 | $15.4B | Buy |
|
|||||
|
2019
Q2 | $18.5B | Sell |
|
|||||
|
2019
Q1 | $18.9B | Sell |
|
|||||
|
2018
Q4 | $20.2B | Buy |
|
|||||
|
2018
Q3 | $19.9B | Sell |
|
|||||
|
2018
Q2 | $16.5B | Sell |
|
|||||
|
2018
Q1 | $16.3B | Buy |
|
|||||
|
2017
Q4 | $16.4B | Buy |
|
|||||
|
2017
Q3 | $15.7B | Sell |
|
|||||
|
2017
Q2 | $14.8B | Sell |
|
|||||
|
2017
Q1 | $15.3B | Buy |
|
|||||
|
2016
Q4 | $496M | Buy |
|
|||||
|
2016
Q3 | $512M | Buy |
|
|||||
|
2016
Q2 | $527M | Buy |
|
|||||
|
2016
Q1 | $421M | Sell |
|
|||||
|
2015
Q4 | $597M | Buy |
|
|||||
|
2015
Q3 | $553M | Buy |
|
|||||
|
2015
Q2 | $539M | Sell |
|
|||||
|
2015
Q1 | $646M | Sell |
|
|||||
|
2014
Q4 | $614M | Sell |
|
|||||
|
2014
Q3 | $590M | Sell |
|
|||||
|
2014
Q2 | $634M | Buy |
|
|||||
|
2014
Q1 | $567M | Sell |
|
|||||
|
2013
Q4 | $582M | Buy |
|
|||||
|
2013
Q3 | $502M | Sell |
|
|||||
|
2013
Q2 | $505M | Buy |
|